Chinook Therapeutics Inc (NASDAQ:KDNY)
| 24.80 Delayed Data As of 3:59pm ET |  -1.12 / -4.32%Today’s Change | 11.16 Today|||52-Week Range 27.44 | -5.34% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Samsara Biocapital Llc Director |  Buy | 5/27/2022 | 570,000 | $14.00 | $8.0M | +68.09% |
Dobmeier Eric L President & Chief Executive Officer |  Sale | 12/01/2022 | 30,000 | $22.31 | $669.3K | +15.30% |
King Andrew /chinook/ Chief Scientific Officer | Sale | 1/03/2023 | 10,000 | $25.82 | $258.2K | +1.89% |
Frohlich Tom /versant Ventures/ Chief Operating Officer | Sale | 12/13/2022 | 10,000 | $25.00 | $250.0K | +3.56% |
Frohlich Tom /versant Ventures/ Chief Operating Officer | Sale | 11/07/2022 | 10,000 | $22.16 | $221.6K | +14.89% |
Thomas Dolca Director | Buy | 9/02/2022 | 9,700 | $21.22 | $205.8K | +22.15% |
Frohlich Tom /versant Ventures/ Chief Operating Officer | Sale | 10/06/2022 | 7,360 | $19.69 | $144.9K | +30.38% |
Bjerkholt Eric Hands Claude Chief Financial Officer | Sale | 12/01/2022 | 5,770 | $22.29 | $128.6K | +15.30% |
King Andrew /chinook/ Chief Scientific Officer | Sale | 8/04/2022 | 5,000 | $20.00 | $100.0K | +27.25% |
King Andrew /chinook/ Chief Scientific Officer | Sale | 7/11/2022 | 5,000 | $18.09 | $90.5K | +44.48% |
Page of 4